Fundraising FoxRed Cell Incubation — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Envisagenicsenvisagenics.cominSep 2021
Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.
AI & Machine LearningBiotechMedical DevicesNew York, US
Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Founder)inMaria Luisa Pineda(Founder)in
Co-investorsDolby Family VenturesDynamk CapitalHAWKTAILM12 (Microsoft's Venture Fund)Madrona Venture GroupThird Kind Venture Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.